![Michael Henderson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Henderson
Chief Executive Officer at APOGEE THERAPEUTICS, INC.
Net worth: 28 M $ as of 30/05/2024
Network origin in Michael Henderson first degree
Entity | Entity type | Industry | |
---|---|---|---|
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.
71
| Private Company | Miscellaneous Commercial Services | 71 |
Public Company | Biotechnology | 28 | |
Public Company | Biotechnology | 22 | |
Public Company | Biotechnology | 19 | |
QED Therapeutics, Inc.
![]() QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., QED Therapeutics, Inc. is a biotechnology company based in Palo Alto, CA. The company focuses on precision medicine for FGFR-driven diseases and is committed to finding solutions to FGFR-driven cancers and diseases to give patients more possibilities. QED Therapeutics' lead investigational candidate is infigratinib, an orally administered, FGFR1-3 selective tyrosine kinase inhibitor that has shown activity in patients with chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions and advanced urothelial carcinoma with FGFR3 genomic alterations. In 2020, QED submitted a new drug application (NDA) with the Food and Drug Administration for second- and later-line cholangiocarcinoma. Michael Henderson has been the CEO of the company since 2017.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Public Company | Financial Conglomerates | 6 | |
Origin Biosciences, Inc.
![]() Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., Origin Biosciences, Inc. is an actively managed investment issuer focused on making equity investments in psychedelics industry-related companies to provide investors with diverse exposure to the sector. The company is based in Palo Alto, CA. The company, led by a team of industry experts, leverages its management expertise, professional network, and due diligence process to identify and invest in leading and emerging companies focused on the emerging psychedelics sector. Michael Henderson has been the CEO of the company since 2018.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Adrenas Therapeutics, Inc.
1
| Subsidiary | 1 | |
Therasis, Inc.
![]() Therasis, Inc. Pharmaceuticals: MajorHealth Technology Therasis, Inc. develops oncology drugs. It offers oncology therapeutics for use as single agents or in combination therapy. The firm's proprietary technology, the Therasis Filter, represents a paradigm shift in the ability to discover therapeutic targets, their chemical inhibitors, and associated biomarkers and this platform integrates world-class expertise in high throughput screening, systems biology, cancer genetics and clinical research. The company was founded by Owen A. O'Connor and Riccardo Dalla-Favera in 2007 and is headquartered in New York, NY.
1
| Private Company | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael Henderson via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
PROMETHEUS BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member Investor Relations Contact Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
BridgeBio Pharma LLC
![]() BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Founder Corporate Officer/Principal | |
EIDOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO Chief Tech/Sci/R&D Officer Chief Executive Officer Director/Board Member | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
ARYA SCIENCES ACQUISITION CORP V | Financial Conglomerates | Founder Founder Founder Director/Board Member Founder | |
University of Oxford | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Graduate Degree Graduate Degree Graduate Degree | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
Perceptive Advisors (Private Equity)
![]() Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors (Private Equity) (Perceptive Advisors) is a private equity subsidiary of Perceptive Advisors LLC founded in 1999 by Joseph Eric Edelman. The firm is headquartered in New York. | Investment Managers | Chief Executive Officer Private Equity Analyst Chief Investment Officer Corporate Officer/Principal | |
Northwestern University
![]() Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Warburg Pincus LLC
![]() Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Investment Managers | Corporate Officer/Principal Private Equity Investor Private Equity Investor | |
Stanford University | College/University | Graduate Degree Graduate Degree Doctorate Degree | |
Bausch & Lomb, Inc.
![]() Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Chief Executive Officer Chairman Corporate Officer/Principal | |
Brigham Young University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Texas A&M University | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
Fordham University
![]() Fordham University Other Consumer ServicesConsumer Services Fordham University provides college and university. It offers undergraduate colleges and graduate & professional schools. The company was founded in 1841 and is headquartered in Bronx, NY. | College/University | Masters Business Admin Masters Business Admin Graduate Degree | |
Navire Pharma, Inc.
![]() Navire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Navire Pharma, Inc. engages in the development of therapeutics to treat multiple cancers. It focuses on SHP2, a protein-tyrosine phosphatase that links growth factor, cytokine and integrin signalling with the downstream RAS/ERK MAPK pathway to regulate cellular proliferation and survival. The company was founded by Phil Jones and Benjamin Neel in 2017 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer Chief Tech/Sci/R&D Officer | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Third Rock Ventures LLC
![]() Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Private Equity Investor Corporate Officer/Principal | |
Council on Foreign Relations, Inc.
![]() Council on Foreign Relations, Inc. Investment Trusts/Mutual FundsMiscellaneous Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Columbia Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
AXCA HEALPAR | Biotechnology | Corporate Officer/Principal General Counsel General Counsel | |
University of Pennsylvania | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
LIANBIO | Biotechnology | Chief Executive Officer Founder Director/Board Member | |
The Rockefeller University | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
Perceptive Advisors LLC
![]() Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Joseph “Joe” Edelman in 1999. provides investment advice to private funds, separate accounts, and co-investment vehicles. Investors in the client accounts and co-investment vehicles consist primarily of institutional investors, financial institutions, other investment funds, and high-net-worth individuals. | Investment Managers | Chief Executive Officer Analyst-Fixed Income Chief Investment Officer | |
SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
The University of Texas at Austin | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
Haas School of Business | College/University | Masters Business Admin Masters Business Admin | |
Arizona State University | College/University | Undergraduate Degree Undergraduate Degree | |
University of Cambridge | College/University | Graduate Degree Graduate Degree | |
INVITAE CORPORATION | Medical/Nursing Services | Chairman Director/Board Member | |
Viridian LLC
![]() Viridian LLC BiotechnologyHealth Technology Viridian LLC operates as a biopharmaceutical incubator. It focuses in the discovery and development of new molecular entities. The company was founded by Peter Harwin and Tomas Kiselak in 2016 and is headquartered in Philadelphia, PA. | Biotechnology | Founder Founder | |
University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Venrock Associates
![]() Venrock Associates Investment ManagersFinance Venrock Associates is an Independent Venture Capital firm founded in 1969. The firm is headquartered in Palo Alto. | Investment Managers | Private Equity Investor Private Equity Investor | |
SURFACE ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
AMGEN INC. | Pharmaceuticals: Major | Director/Board Member Comptroller/Controller/Auditor | |
JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer |
Statistics
International
United States | 46 |
United Kingdom | 3 |
Mexico | 2 |
Ireland | 2 |
Sectoral
Consumer Services | 21 |
Health Technology | 17 |
Finance | 12 |
Miscellaneous | 2 |
Health Services | 2 |
Operational
Director/Board Member | 367 |
Corporate Officer/Principal | 236 |
Independent Dir/Board Member | 127 |
Undergraduate Degree | 93 |
Chief Executive Officer | 64 |
Most connected contacts
Insiders | |
---|---|
Brenton Saunders | 39 |
Anjali Bansal | 37 |
Fred Hassan | 30 |
Eric Aguiar | 29 |
Jane Henderson | 25 |
Alison Lawton | 25 |
Donna Milrod | 22 |
V. Lawlis | 21 |
Adam Stone | 18 |
Michelle Jarrard | 18 |
Ivana Magovcevic-Liebisch | 18 |
Neil Kumar | 18 |
Armen Shanafelt | 17 |
Ronald Daniels | 17 |
Anish Melwani | 17 |
- Stock Market
- Insiders
- Michael Henderson
- Company connections